T. Rowe Price Associates’s Arcosa ACA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $30M | Buy |
282,398
+154,201
| +120% | +$17.5M | ﹤0.01% | 933 |
|
|
2025
Q4 | $13.6M | Buy |
128,197
+81,103
| +172% | +$8.19M | ﹤0.01% | 1161 |
|
|
2025
Q3 | $4.41M | Buy |
47,094
+2,236
| +5% | +$208K | ﹤0.01% | 1433 |
|
|
2025
Q2 | $3.89M | Buy |
44,858
+4,800
| +12% | +$402K | ﹤0.01% | 1358 |
|
|
2025
Q1 | $3.09M | Buy |
40,058
+1,889
| +5% | +$173K | ﹤0.01% | 1413 |
|
|
2024
Q4 | $3.69M | Sell |
38,169
-2,348
| -6% | -$236K | ﹤0.01% | 1377 |
|
|
2024
Q3 | $3.84M | Buy |
40,517
+90
| +0.2% | +$7.86K | ﹤0.01% | 1378 |
|
|
2024
Q2 | $3.37M | Buy |
40,427
+1,428
| +4% | +$119K | ﹤0.01% | 1359 |
|
|
2024
Q1 | $3.35M | Buy |
38,999
+1,761
| +5% | +$143K | ﹤0.01% | 1346 |
|
|
2023
Q4 | $3.08M | Buy |
37,238
+1,947
| +6% | +$143K | ﹤0.01% | 1360 |
|
|
2023
Q3 | $2.54M | Buy |
35,291
+98
| +0.3% | +$7.43K | ﹤0.01% | 1374 |
|
|
2023
Q2 | $2.67M | Buy |
35,193
+575
| +2% | +$38.7K | ﹤0.01% | 1377 |
|
|
2023
Q1 | $2.19M | Buy |
34,618
+1,046
| +3% | +$61.4K | ﹤0.01% | 1434 |
|
|
2022
Q4 | $1.82M | Buy |
33,572
+145
| +0.4% | +$8.61K | ﹤0.01% | 1502 |
|
|
2022
Q3 | $1.91M | Sell |
33,427
-13,037
| -28% | -$723K | ﹤0.01% | 1478 |
|
|
2022
Q2 | $2.16M | Sell |
46,464
-724
| -2% | -$37.9K | ﹤0.01% | 1586 |
|
|
2022
Q1 | $2.7M | Sell |
47,188
-226,729
| -83% | -$11.7M | ﹤0.01% | 1592 |
|
|
2021
Q4 | $14.4M | Sell |
273,917
-1,954
| -0.7% | -$104K | ﹤0.01% | 1347 |
|
|
2021
Q3 | $13.8M | Buy |
275,871
+12,868
| +5% | +$667K | ﹤0.01% | 1380 |
|
|
2021
Q2 | $15.4M | Buy |
263,003
+150,636
| +134% | +$9.32M | ﹤0.01% | 1358 |
|
|
2021
Q1 | $7.31M | Buy |
112,367
+63,682
| +131% | +$3.91M | ﹤0.01% | 1429 |
|
|
2020
Q4 | $2.67M | Buy |
48,685
+5,698
| +13% | +$291K | ﹤0.01% | 1556 |
|
|
2020
Q3 | $1.9M | Sell |
42,987
-18,891
| -31% | -$830K | ﹤0.01% | 1563 |
|
|
2020
Q2 | $2.61M | Sell |
61,878
-1,075
| -2% | -$41.4K | ﹤0.01% | 1478 |
|
|
2020
Q1 | $2.5M | Buy |
62,953
+10,864
| +21% | +$459K | ﹤0.01% | 1453 |
|
|
2019
Q4 | $2.32M | Buy |
52,089
+1,931
| +4% | +$74.3K | ﹤0.01% | 1562 |
|
|
2019
Q3 | $1.72M | Buy |
50,158
+223
| +0.4% | +$7.72K | ﹤0.01% | 1618 |
|
|
2019
Q2 | $1.88M | Buy |
49,935
+1,525
| +3% | +$52.2K | ﹤0.01% | 1614 |
|
|
2019
Q1 | $1.48M | Buy |
48,410
+8,274
| +21% | +$253K | ﹤0.01% | 1696 |
|
|
2018
Q4 | $1.11M | Buy |
+40,136
| New | +$1.1M | ﹤0.01% | 1759 |
|
Other funds holding ACA
VPM
VCM
RA
T. Rowe Price Associates's ACA Position: Q1 2026 in Review
T. Rowe Price Associates increased its Arcosa (ACA) stake by 120% in Q1 2026, buying an estimated $17.5M and bringing the position to 282,398 shares worth $30M. The position accounts for ﹤0.01% of the portfolio, ranked #933.
T. Rowe Price Associates first reported a position in ACA in Q4 2018 and has held it in 30 quarters since. 372 funds tracked by Wall St. Rank hold ACA as of Q1 2026.
- T. Rowe Price Associates held 282,398 shares of Arcosa worth $30M as of Q1 2026.
- T. Rowe Price Associates bought 154,201 Arcosa shares in Q1 2026, an estimated $17.5M.
- Arcosa made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #933 holding.
- T. Rowe Price Associates first reported a position in Arcosa in Q4 2018 and has held it in 30 quarters since.
- 372 funds tracked by Wall St. Rank held Arcosa as of Q1 2026.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.